Biocon Future and Option Prediction for Tomorrow 1 June 2026: Key Levels and Strategy

May 31, 2026
Posted by: Kunal Singla
Category: News

The Biocon future and option prediction for tomorrow on 1 June 2026 is bearish, based on Biocon closing at Rs 426 on 29 May 2026 (-1.44%). GIFT Nifty at 23,860.0 (+201.5 pts, +0.85%) signals a positive gap-up for Indian markets on 1 June. Nifty 50 closed at 23,649.95 on 29 May 2026, supported by a 3.2 per cent Nifty IT rally. FII net selling of Rs 21,105.86 crore on 29 May 2026 and below-normal monsoon concerns are the key risk factors for the biocon future and option prediction for tomorrow.

Click Here – Get Free Investment Predictions

Table of Contents

Biocon Share Price Recap on 29 May 2026

CMP (29 May 2026 Close): Rs 426 (-1.44%)

Sector: Biopharmaceuticals | 52W High: Rs 542 | 52W Low: Rs 345 | Lot Size: 2,800

Biocon fell marginally on 29 May despite a broadly positive pharma sector session led by Sun Pharma and Cipla. Biocon faces specific headwinds from its biologics restructuring and US biosimilar pricing pressure that differentiate it from mainstream branded generic companies.

Biocon Futures Prediction for Tomorrow 1 June 2026

Futures Trend: Bearish

Futures Price (Approx): Rs 426

Support 1: Rs 418 | Support 2: Rs 408

Resistance 1: Rs 436 | Resistance 2: Rs 447

Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Biocon future and option prediction for tomorrow places Rs 418 as the critical immediate support for the 1 June session. With GIFT Nifty indicating a gap-up open of 201.5 points, the early session direction will be pivotal. Jaiswal flags Rs 436 as the first resistance level. A gap-up open above Rs 418 that sustains in the first 15-minute candle confirms the bearish continuation for Biocon futures on 1 June 2026.

Biocon Options Analysis for 1 June 2026

PCR: 0.82 | Max Call OI: Rs 436 strike | Max Put OI: Rs 418 strike

Kunal Singla, Associate Director at Univest, observes that the Biocon options chain shows maximum call OI at Rs 436 and maximum put OI at Rs 418. The PCR of 0.82 reflects cautious positioning with call OI exceeding put OI. On the gap-up open driven by GIFT Nifty at +201.5 points, Singla suggests watching Rs 418 as the intraday support floor for options-based positioning in Biocon on 1 June.

Key Triggers for Biocon on 1 June 2026

GIFT Nifty Gap-Up (+201.5 pts): The positive pre-market signal sets a constructive base for Biocon futures on 1 June.
Biocon Biologics restructuring progress: Primary sector-specific catalyst for Biocon direction on 1 June 2026.
US biosimilar pricing environment: Secondary trigger to watch in the first half of the session.
FII Flow Reversal: FII selling of Rs 21,105.86 crore on 29 May 2026 resets on 1 June as a new month begins. Positive FII flow would accelerate bearish momentum in Biocon.

Trading Strategy for Biocon Futures and Options on 1 June 2026

1. Gap-Up Confirmation: Wait for the first 15-minute candle above Rs 418 before entering Biocon futures. Do not chase the gap-up open.

2. Bull Setup: If Biocon holds above Rs 418 and breaks Rs 436 on volume, the futures target is Rs 447 for the session.

3. Bear Setup: A break below Rs 408 on sustained selling confirms a bearish reversal. Exit longs and avoid buying on the dip below this level.

4. Options Strategy: With PCR at 0.82, consider defined-risk spreads for the 1 June session. Naked options carry elevated risk on a gap-up expiry week open.

Download the Univest iOS App or Univest Android App for daily expert predictions and live market data.

Conclusion

The Biocon future and option prediction for tomorrow 1 June 2026 is bearish, with key support at Rs 418 and resistance at Rs 436. Biocon closed at Rs 426 on 29 May 2026 (-1.44%). GIFT Nifty at +201.5 points provides a positive gap-up backdrop. Ankit Jaiswal of Univest places Rs 418 as the session support and Kunal Singla of Univest flags Rs 436 call OI as the resistance ceiling. All Biocon future and option prediction for tomorrow levels are educational analysis only. Consult a SEBI-registered advisor before trading.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Frequently Asked Questions

What is the Biocon future and option prediction for tomorrow 1 June 2026?

Ans. The Biocon future and option prediction for tomorrow is bearish. CMP is Rs 426 (-1.44% on 29 May 2026). Support is at Rs 418 and resistance at Rs 436. GIFT Nifty at +201.5 points signals a positive gap-up open. PCR for Biocon options is 0.82 with max call OI at Rs 436.

What is the support level for Biocon futures on 1 June 2026?

Ans. Support levels for Biocon futures on 1 June 2026 are Rs 418 (immediate) and Rs 408 (secondary). Ankit Jaiswal of Univest identifies Rs 418 as the make-or-break level for the Biocon future and option prediction for tomorrow.

What is the resistance level for Biocon on 1 June 2026?

Ans. Resistance for Biocon on 1 June 2026 is Rs 436 (immediate) and Rs 447 (next resistance). Maximum call OI at Rs 436 acts as the upper boundary for the Biocon future and option prediction for tomorrow.

What is the PCR for Biocon options on 1 June 2026?

Ans. The PCR for Biocon options is 0.82. Max call OI is at Rs 436 and max put OI at Rs 418. Kunal Singla of Univest observes this PCR as a cautious signal for the Biocon future and option prediction for tomorrow.

What are the key triggers for Biocon on 1 June 2026?

Ans. Key triggers for Biocon on 1 June 2026 include: GIFT Nifty gap-up of +201.5 points, biocon biologics restructuring progress, us biosimilar pricing environment, and potential FII flow reversal at the start of June. These determine the Biocon future and option prediction for tomorrow direction.

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.